Breaking News

JPMorgan Said to Mull Raising Some Staff Salaries at Least 20%
Tweet TWEET

Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2013 Financial Results on March 13,

Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter  and Full Year 2013 Financial Results on March 13, 2014  DEERFIELD, IL -- (Marketwired) -- 02/27/14 --   Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that its fourth quarter and year ended December 31, 2013 financial results will be released on Thursday, March 13, 2014. Following the announcement, Horizon's management will host a live conference call and webcast at 8:00 am Eastern Time to review the Company's financial and operating results and provide a general business update.   The live webcast and a replay may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com. Please connect to the Company's website at least 15 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. Alternatively, please call 1-888-338-8373 (U.S.) or 973-872-3000 (international) to listen to the conference call. The conference ID number for the live call is 58632547. Telephone replay will be available approximately two hours after the call. To access the replay, please call 1-855-859-2056 (U.S.) or 404-537-3406 (international). The conference ID number for the replay is 58632547.  About Horizon Pharma  Horizon Pharma, Inc. is a commercial stage, specialty pharmaceutical company that markets DUEXIS(R), RAYOS(R)/LODOTRA(R) and VIMOVO(R), which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The Company's strategy is to develop, acquire or in-license additional innovative medicines or companies where it can execute a targeted commercial approach among specific target physicians such as primary care physicians, orthopedic surgeons and rheumatologists, while taking advantage of its commercial strengths and the infrastructure the Company has put in place. For more information, please visit www.horizonpharma.com.  Contacts: Robert J. De Vaere Executive Vice President and Chief Financial Officer investor-relations@horizonpharma.com     
Press spacebar to pause and continue. Press esc to stop.